GE HealthCare to distribute NordicNeuroLab fMRI tools
The agreement covers nordicMEDiVA, nordicAktiva, selected MRI hardware, and patient comfort products across authorized global markets.
GE HealthCare will integrate and distribute NordicNeuroLab’s functional MRI software within its MRI platform ecosystem under a software license and distribution agreement, according to NordicNeuroLab. The agreement covers authorized markets worldwide.
The software portfolio includes nordicMEDiVA and nordicAktiva. NordicNeuroLab said selected MRI hardware and patient comfort products, including nordicComfortSolution, are also part of the agreement.
The collaboration is structured around functional MRI, diffusion imaging, and neuro post-processing. The companies said the framework is designed for cloud-based and on-premise deployments across regions.
NordicNeuroLab will retain ownership of its software technology. The company will also provide training, service, and lifecycle support, according to the announcement.
nordicMEDiVA is a web-based neuroimaging platform from NordicNeuroLab. The product page lists modules for task-based fMRI, diffusion and tractography, and DSC perfusion.
FDA records list nordicMEDiVA under 510(k) K243209 as a radiological image-processing system from NordicNeuroLab. The device received a substantially equivalent decision in 2024.
NordicNeuroLab said its collaboration with GE Healthcare began in 2017. The company’s GE Healthcare page says it has supplied MR-conditional equipment for fMRI as part of that collaboration.
Company:GE HealthCare
GE HealthCare coverage
Sources
- 510(k) Premarket Notification K243209, nordicMEDiVA. Regulatory filing
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
CBCT perfusion collaboration targets stroke angio suite
Siemens Healthineers and Cercare Medical are pairing Syngo DynaCT Multiphase with Neurosuite to support perfusion imaging during acute stroke interventions.
Pathology support broadens MedDream viewer scope
Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.
DOSIsoft unit gives PLANET a theranostics focus
DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.
Vault-ready proton system headed to Tam Anh
Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.
I-MED sale gives Jardines 215-clinic radiology network
Jardine Matheson will acquire 100% of I-MED Radiology Network in a deal valued at A$3.4B, including I-MED’s minority stake in Harrison.ai.
Expected Russell addition puts Hyperfine in small-cap benchmarks
FTSE Russell’s preliminary June reconstitution list includes Hyperfine, with index changes set to take effect after U.S. markets close on June 26.
Curium approach puts Lantheus deal value near $7B
Lantheus is weighing a potential sale after an approach from Curium Pharma, while company filings show recent Pylarify pressure and pending PET regulatory milestones.
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.